Avantium N.V (AVTX) | Financial Analysis & Statements
Avantium N.V. | Small-cap | Basic Materials
Avantium N.V. | Small-cap | Basic Materials
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
21.0M
Gross Profit
16.4M
77.80%
Operating Income
-38.5M
-183.07%
Net Income
-32.6M
-155.10%
EPS (Diluted)
-€0.36
Balance Sheet Metrics
Total Assets
288.6M
Total Liabilities
190.8M
Shareholders Equity
97.8M
Debt to Equity
1.95
Cash Flow Metrics
Operating Cash Flow
-31.0M
Free Cash Flow
-94.6M
Revenue & Profitability Trend
Avantium N.V Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 21.0M | 19.7M | 17.8M | 10.9M | 9.9M |
| Cost of Goods Sold | 4.7M | 4.2M | 3.8M | 3.0M | 2.3M |
| Gross Profit | 16.4M | 15.5M | 14.1M | 7.9M | 7.5M |
| Operating Expenses | 18.4M | 17.3M | 14.6M | 11.4M | 12.1M |
| Operating Income | -38.5M | -34.9M | -24.9M | -23.9M | -22.5M |
| Pre-tax Income | -32.6M | -34.2M | -29.7M | -24.4M | -22.8M |
| Income Tax | 0 | 0 | 0 | 0 | 0 |
| Net Income | -32.6M | -34.2M | -29.7M | -24.4M | -22.8M |
| EPS (Diluted) | -€0.36 | -€0.61 | -€0.59 | -€0.69 | -€0.74 |
Income Statement Trend
Avantium N.V Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 42.4M | 54.3M | 75.5M | 43.0M | 35.2M |
| Non-Current Assets | 246.3M | 174.2M | 88.1M | 34.6M | 34.8M |
| Total Assets | 288.6M | 228.5M | 163.6M | 77.7M | 70.0M |
| Liabilities | |||||
| Current Liabilities | 171.1M | 52.7M | 33.8M | 18.5M | 15.7M |
| Non-Current Liabilities | 19.7M | 121.9M | 36.8M | 9.1M | 8.0M |
| Total Liabilities | 190.8M | 174.6M | 70.6M | 27.6M | 23.7M |
| Equity | |||||
| Total Shareholders Equity | 97.8M | 53.9M | 93.0M | 50.0M | 46.2M |
Balance Sheet Composition
Avantium N.V Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -32.6M | -34.2M | -29.7M | -24.4M | -22.8M |
| Operating Cash Flow | -31.0M | -38.8M | -30.0M | -21.7M | -17.7M |
| Investing Activities | |||||
| Capital Expenditures | -58.3M | -89.3M | -33.8M | -3.9M | -3.4M |
| Investing Cash Flow | -58.3M | -89.3M | -13.8M | -3.9M | -3.4M |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | 94.8M | 84.4M | 76.7M | 26.5M | 37.0K |
| Free Cash Flow | -94.6M | -106.7M | -45.1M | -16.5M | -16.9M |
Cash Flow Trend
Avantium N.V Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-35.65
Forward P/E
-26.56
Price to Book
1.17
Price to Sales
5.38
PEG Ratio
-26.56
Profitability Ratios
Profit Margin
-127.72%
Operating Margin
-163.02%
Return on Equity
-43.03%
Return on Assets
-9.30%
Financial Health
Current Ratio
0.25
Debt to Equity
144.79
Beta
1.26
Per Share Data
EPS (TTM)
-€3.60
Book Value per Share
€11.13
Revenue per Share
€2.79
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| avtx | 113.2M | -35.65 | 1.17 | -43.03% | -127.72% | 144.79 |
| Pharming Group N.V | 637.6M | 57.15 | 2.88 | -6.78% | -4.40% | 55.34 |
| Vivoryon | 39.2M | -1.85 | 4.97 | -120.41% | 0.00% | 1.29 |
| Aegon | 9.3B | 15.76 | 1.27 | 7.17% | 5.36% | 74.02 |
| Galapagos NV | 1.6B | 51.71 | 0.57 | -6.36% | -58.83% | 0.40 |
| Koninklijke Philips | 18.0B | 74.96 | 1.54 | 1.99% | 2.08% | 64.54 |
Financial data is updated regularly. All figures are in the company's reporting currency.